secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001104659-23-076373
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie appoints Robert A. Michael as President and COO effective June 29, 2023
------------------------------------------------------------------------------

- Robert A. Michael appointed President and Chief Operating Officer effective June 29, 2023.
- He will continue oversight of AbbVie's global commercial and financial operations.
- New responsibilities include operations, human resources, business development, and corporate strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923076373/0001104659-23-076373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923076373/tm2320134d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-076373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer